## CLX: Clorox Company (The) - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -0.1% below STRENGTH zone (4.0-10.0%); PEG 3.35 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($99.35)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 2)

**1. Hudson Bay Capital Management LP Makes New $8.57 Million Investment in The Clorox Company $CLX**
- Source: MarketBeat | 20251215T105909 | Somewhat-Bullish | Relevance: 100%
- Hudson Bay Capital Management LP has invested $8.57 million in The Clorox Company by purchasing 71,362 shares, representing about 0.06% ownership. This move follows Clorox beating its quarterly EPS estimates and setting FY2026 guidance, alongside a director's significant share purchase. Institutional investors and hedge funds own 78.53% of Clorox stock.

**2. Clorox's Brand Investments Are Up: Will They Translate to Growth?**
- Source: TradingView | 20251212T150757 | Somewhat-Bearish | Relevance: 100%
- Clorox is increasing brand investments, including trade spending and advertising, to support innovations despite ERP-related disruptions impacting recent sales. While net sales and organic sales declined in the first quarter of fiscal 2026 due to these issues, the company expects continued pressures for the year but remains committed to maintaining advertising and promotional spending. Clorox believes its investment and innovation pipeline will help regain momentum and stabilize demand as operational challenges subside.

**3. 41,458 Shares in The Clorox Company $CLX Acquired by Occudo Quantitative Strategies LP**
- Source: MarketBeat | 20251212T125814 | Neutral | Relevance: 100%
- Occudo Quantitative Strategies LP has acquired a new stake of 41,458 shares in The Clorox Company (NYSE:CLX), valued at approximately $4.98 million. This acquisition is part of broader institutional trading activity, with major investors like Vanguard and Invesco also adjusting their holdings. Clorox recently reported beating Q1 EPS estimates but faced a year-over-year revenue decline, leading analysts to trim price targets and maintain a "Reduce" consensus rating, despite a strong dividend yield and insider buying activity.

**4. Is Clorox Stock Underperforming the S&P 500?**
- Source: Markets Financial Content | 20251212T085200 | Bearish | Relevance: 100%
- The Clorox Company (CLX) is significantly underperforming the S&P 500, with its shares down 36.7% year-to-date compared to the S&P 500's 17.3% return. Despite better-than-expected Q1 earnings, the stock plunged due to a substantial year-over-year decline in revenue and adjusted EPS, largely attributed to an ERP transition. Analysts maintain a "Hold" rating on CLX, with a mean price target suggesting a 20.5% premium to its current price.

**5. Clorox Tests Social Commerce Strategy With TikTok Shop**
- Source: Net Influencer | 20251211T145611 | Bullish | Relevance: 100%
- Clorox is actively testing a social commerce strategy on TikTok Shop, expanding beyond Burt's Bees to include Brita, Pine-Sol, and Hidden Valley. This initiative aims to engage younger consumers, facilitate impulse purchases, gain full-funnel insights, and adapt its brand portfolio to creator-led cultural norms. The company sees TikTok Shop as a crucial testing ground for how household brands can thrive in a commerce model driven by short-form content and creator promotions, especially given TikTok Shop's significant growth in sales and consumer engagement.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 12 ($9.83M) |
| Sells | 4 ($1.06M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.9% (-0.7%)
- Blackrock Inc.: 8.5% (-1.2%)
- State Street Corpora: 6.9% (+3.5%)
- Invesco Ltd.: 3.3% (+23.1%)
- Morgan Stanley: 2.6% (+18.3%)

### Key Risks

1. Valuation stretched: PEG 3.3x requires aggressive growth execution.
2. Long-term trend broken: trading 17.5% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.35 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 44%, ROA 12%). Insider buying signal ($9.8M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.7B |
| Beta | 0.57 |
| 52W Range | $98.20 - $166.35 |
| Short Interest | 6.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.35 |
| Forward P/E | 15.4 |
| Current P/E | 17.4 |
| YoY Growth | 13.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -5.0% to -0.1% (+4.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.1pp (needs >4.0% for momentum thesis). MRS_5 turning positive (3.0%) - potential reversal signal. Below SMA200 (0.82x), long-term trend not supportive. RSI neutral at 44. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.12% (CS: 37) | Neutral |
| RSI_14 | 44.4 | Neutral |
| MACD Histogram | 0.28 | Bullish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 0.944x | Below |
| vs SMA200 | 0.825x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $104.01
- **Stop Loss:** $99.35 (4.5% risk)
- **Target:** $108.67 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 257
- **Position Value:** $26,730.57
- **Portfolio %:** 26.73%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-03 (Est: $1.45)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.78 | $0.85 | +9.2% |
| 2025Q2 | $2.21 | $2.87 | +29.8% |
| 2025Q1 | $1.56 | $1.45 | -6.9% |
| 2024Q4 | $1.40 | $1.55 | +10.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*